Supported by science

The Omega-3 fatty acids EPA and DHA have important roles in human health. Experts agree that EPA and DHA are a safe and effective option for reducing plasma triglycerides, and that EPA in particular is important for cardiovascular disease risk management.

In addition to their recognized roles in cardiovascular disease risk management, omega-3 fatty acids are under investigation as potential therapeutic candidates for a variety of health conditions, ranging from stroke, traumatic brain injury, even as a treatment for chemotherapy-related complications.

We are not just limited to EPA and DHA. DSM has the unique capability to produce a variety of lipid products from marine oils and algal fermentation to meet your custom specification. We want to work with you to get your product into the hands of patients around the world.

Contact us to find out more about how we can help you bring your lipid-based APIs to the market.

DSM Benefits


DSM has the ability to produce our lipid products to meet the potency and purity that your custom specification demands from either marine or fermentation-based sources.


Our state-of-the-art production facilities offer ICH Q7 compliant quality production, and are FDA, FSSC, and CFIA audited. In addition, DSM has a dedicated group of experts working to monitor marine oil contaminants, and our world-class analytical team has advanced test method development capabilities to help us stay ahead of an ever-changing environment.

Security and History

With the world’s largest and longest operating capacity to produce both marine and fermentative based lipid products DSM has been able to offer stable and secure supply for over 25 years.